{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:37:44Z","timestamp":1789519064402,"version":"build-2803163510"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Research Foundation of Heilongjiang University of Chinese Medicine","award":["No. 2019BJP02"],"award-info":[{"award-number":["No. 2019BJP02"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873108"],"award-info":[{"award-number":["No. 81873108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Excellent Creative Talents Support Program of Heilongjiang University of Chinese Medicine","award":["No. 2018RCQ08"],"award-info":[{"award-number":["No. 2018RCQ08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11064-023-04061-0","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:41:29Z","timestamp":1701186089000},"page":"548-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathogenesis of Depression in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Qingyang","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"4061_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h369","volume":"350","author":"HC Kales","year":"2015","unstructured":"Kales HC, Gitlin LN, Lyketsos CG (2015) Assessment and management of behavioral and psychological symptoms of Dementia. BMJ 350:h369. https:\/\/doi.org\/10.1136\/bmj.h369","journal-title":"BMJ"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS (2011) Neuropsychiatric symptoms in Alzheimer\u2019s Disease. Alzheimers Dement 7:532\u2013539.\u00a0https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2410","journal-title":"Alzheimers Dement"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","volume":"190","author":"QF Zhao","year":"2016","unstructured":"Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Xu W, Li JQ, Wang J, Lai TJ, Yu JT (2016) The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s Disease: systematic review and meta-analysis. J Affect Disord 190:264\u2013271.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2015.09.069","journal-title":"J Affect Disord"},{"key":"4061_CR4","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17r11772","volume":"79","author":"MS Asmer","year":"2018","unstructured":"Asmer MS, Kirkham J, Newton H, Ismail Z, Elbayoumi H, Leung RH, Seitz DP (2018) Meta-analysis of the prevalence of major depressive disorder among older adults with dementia. J Clin Psychiatry\u00a079:17r11772.\u00a0https:\/\/doi.org\/10.4088\/JCP.17r11772","journal-title":"J Clin Psychiatry"},{"key":"4061_CR5","doi-asserted-by":"publisher","first-page":"e1276","DOI":"10.1212\/WNL.0000000000012598","volume":"97","author":"WS Eikelboom","year":"2021","unstructured":"Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, Teunissen CE, van Berckel BNM, Pijnenburg YAL, Scheltens P, van der Flier WM, Ossenkoppele R, Papma JM (2021) Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical spectrum: cross-sectional and longitudinal associations. Neurology 97:e1276\u2013e1287.\u00a0https:\/\/doi.org\/10.1212\/WNL.0000000000012598","journal-title":"Neurology"},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/alz.12358","volume":"17","author":"DS Miller","year":"2021","unstructured":"Miller DS, Robert P, Ereshefsky L, Adler L, Bateman D, Cummings J, DeKosky ST, Fischer CE, Husain M, Ismail Z, Jaeger J, Lerner AJ, Li A, Lyketsos CG, Manera V, Mintzer J, Moebius HJ, Mortby M, Meulien D, Pollentier S, Porsteinsson A, Rasmussen J, Rosenberg PB, Ruthirakuhan MT, Sano M, Zucchero Sarracini Z, Lanct\u00f4t KL (2021) Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement 17:1892\u20131904.\u00a0https:\/\/doi.org\/10.1002\/alz.12358","journal-title":"Alzheimers Dement"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-021-00456-1","volume":"16","author":"Y Chen","year":"2021","unstructured":"Chen Y, Dang M, Zhang Z (2021) Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer\u2019s disease: a systematic review of symptom-general and -specific lesion patterns. Mol Neurodegener 16:38.\u00a0https:\/\/doi.org\/10.1186\/s13024-021-00456-1","journal-title":"Mol Neurodegener"},{"key":"4061_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamapsychiatry.2016.3162","volume":"74","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, Mortby ME, Smith EE, Patten SB, Fiest KM (2017) Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry 74:58\u201367.\u00a0https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.3162","journal-title":"JAMA Psychiatry"},{"key":"4061_CR9","doi-asserted-by":"publisher","first-page":"707580","DOI":"10.3389\/fpsyt.2021.707580","volume":"12","author":"WA Wiels","year":"2021","unstructured":"Wiels WA, Wittens MMJ, Zeeuws D, Baeken C, Engelborghs S (2021) Neuropsychiatric symptoms in mild cognitive impairment and dementia due to AD: relation with disease stage and cognitive deficits. Front Psychiatry 12:707580.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2021.707580","journal-title":"Front Psychiatry"},{"key":"4061_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","volume":"65","author":"X Sun","year":"2008","unstructured":"Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ (2008) Amyloid-associated depression: a prodromal depression of Alzheimer\u00a0disease? Arch Gen Psychiatry 65:542\u2013550.\u00a0https:\/\/doi.org\/10.1001\/archpsyc.65.5.542","journal-title":"Arch Gen Psychiatry"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1176\/appi.ajp.160.5.857","volume":"160","author":"GS Zubenko","year":"2003","unstructured":"Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T (2003) A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer\u2019s disease. Am J Psychiatry 160:857\u2013866","journal-title":"Am J Psychiatry"},{"key":"4061_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/jad-2010-100153","volume":"21","author":"PJ Modrego","year":"2010","unstructured":"Modrego PJ (2010) Depression in Alzheimer\u2019s Disease. Pathophysiology, diagnosis, and treatment. J Alzheimers Dis 21:1077\u20131087.\u00a0https:\/\/doi.org\/10.3233\/jad-2010-100153","journal-title":"J Alzheimers Dis"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11065-018-9396-2","volume":"28","author":"JK Kuring","year":"2018","unstructured":"Kuring JK, Mathias JL, Ward L (2018) Prevalence of depression, anxiety and PTSD in people with dementia: a systematic review and meta-analysis. Neuropsychol Rev 28:393\u2013416. https:\/\/doi.org\/10.1007\/s11065-018-9396-2","journal-title":"Neuropsychol Rev"},{"key":"4061_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3233\/JAD-148004","volume":"47","author":"F Novais","year":"2015","unstructured":"Novais F, Starkstein S (2015) Phenomenology of depression in Alzheimer\u2019s disease. J Alzheimers Dis 47:845\u2013855.\u00a0https:\/\/doi.org\/10.3233\/JAD-148004","journal-title":"J Alzheimers Dis"},{"key":"4061_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","volume":"3","author":"SS Mirza","year":"2016","unstructured":"Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H, Ikram MA (2016) 10-Year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry 3:628\u2013635.\u00a0https:\/\/doi.org\/10.1016\/S2215-0366(16)00097-3","journal-title":"Lancet Psychiatry"},{"key":"4061_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","volume":"92","author":"M Johansson","year":"2022","unstructured":"Johansson M, Stomrud E, Johansson PM, Svenningsson A, Palmqvist S, Janelidze S, van Westen D, Mattsson-Carlgren N, Hansson O\u00a0(2022) Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of Alzheimer\u2019s disease pathology and cognitive decline. Biol Psychiatry 92:34\u201343. https:\/\/doi.org\/10.1016\/j.biopsych.2022.01.012","journal-title":"Biol Psychiatry"},{"key":"4061_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","volume":"102","author":"CPC Galts","year":"2019","unstructured":"Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56\u201384.\u00a0https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.002","journal-title":"Neurosci Biobehav Rev"},{"key":"4061_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2020.00279","volume":"11","author":"C Linnemann","year":"2020","unstructured":"Linnemann C, Lang UE (2020) Pathways connecting late-life depression and dementia. Front Pharmacol 11:279.\u00a0https:\/\/doi.org\/10.3389\/fphar.2020.00279","journal-title":"Front Pharmacol"},{"key":"4061_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101203","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zou D, Li Y, Gu S, Dong J, Ma X, Xu S, Wang F, Huang JH (2022) Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals (Basel) 15:1203.\u00a0https:\/\/doi.org\/10.3390\/ph15101203","journal-title":"Pharmaceuticals (Basel)"},{"key":"4061_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22169015","volume":"22","author":"G \u015alifirski","year":"2021","unstructured":"\u015alifirski G, Kr\u00f3l M, Tur\u0142o J (2021) 5-HT receptors and the development of new antidepressants. Int J Mol Sci\u00a022:9015.\u00a0https:\/\/doi.org\/10.3390\/ijms22169015","journal-title":"Int J Mol Sci"},{"key":"4061_CR21","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2022","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA (2023) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry\u00a028:3243\u20133256.\u00a0https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"key":"4061_CR22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.biopsych.2022.10.012","volume":"93","author":"D Erritzoe","year":"2023","unstructured":"Erritzoe D, Godlewska BR, Rizzo G, Searle GE, Agnorelli C, Lewis Y, Ashok AH, Colasanti A, Boura I, Farrell C, Parfitt H, Howes O, Passchier J, Gunn RN, Politis M, Nutt DJ, Cowen PJ, Knudsen GM, Rabiner EA (2023) Brain serotonin release is reduced in patients with depression: a [(11)C]cimbi-36 positron emission tomography study with a d-amphetamine challenge. Biol Psychiatry 93:1089\u20131098.\u00a0https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.012","journal-title":"Biol Psychiatry"},{"key":"4061_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1073858420975711","volume":"28","author":"DJ Haleem","year":"2022","unstructured":"Haleem DJ (2022) Glucocorticoids in the physiological and transcriptional regulation of 5-HT1A receptor and the pathogenesis of depression. Neuroscientist 28:59\u201368.\u00a0https:\/\/doi.org\/10.1177\/1073858420975711","journal-title":"Neuroscientist"},{"key":"4061_CR24","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1007\/s12035-019-1619-x","volume":"56","author":"D Mart\u00edn-Hern\u00e1ndez","year":"2019","unstructured":"Mart\u00edn-Hern\u00e1ndez D, Pereira MP, Tendilla-Beltr\u00e1n H, Madrigal JLM, Garc\u00eda-Bueno B, Leza JC, Caso JR (2019) Modulation of monoaminergic systems by antidepressants in the frontal cortex of rats after chronic mild stress exposure. Mol Neurobiol 56:7522\u20137533.\u00a0https:\/\/doi.org\/10.1007\/s12035-019-1619-x","journal-title":"Mol Neurobiol"},{"key":"4061_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neubiorev.2020.09.001","volume":"119","author":"C Roberts","year":"2020","unstructured":"Roberts C, Sahakian BJ, Robbins TW (2020) Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: lessons from the serotonergic modulation of action selection, learning, affect, and social cognition. Neurosci Biobehav Rev 119:138\u2013167.\u00a0https:\/\/doi.org\/10.1016\/j.neubiorev.2020.09.001","journal-title":"Neurosci Biobehav Rev"},{"key":"4061_CR26","first-page":"353","volume":"317","author":"RM Zweig","year":"1989","unstructured":"Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1989) Neuropathology of aminergic nuclei in Alzheimer\u2019s disease. Prog Clin Biol Res 317:353\u2013365","journal-title":"Prog Clin Biol Res"},{"key":"4061_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnmol.2019.00123","volume":"12","author":"P Krashia","year":"2019","unstructured":"Krashia P, Nobili A, D\u2019Amelio M (2019) Unifying hypothesis of dopamine neuron loss in neurodegenerative diseases: focusing on Alzheimer\u2019s disease. Front Mol Neurosci 12:123.\u00a0https:\/\/doi.org\/10.3389\/fnmol.2019.00123","journal-title":"Front Mol Neurosci"},{"key":"4061_CR28","doi-asserted-by":"publisher","first-page":"1039725","DOI":"10.3389\/fpsyt.2022.1039725","volume":"13","author":"P Krashia","year":"2022","unstructured":"Krashia P, Spoleti E, D\u2019Amelio M (2022) The VTA dopaminergic system a diagnostic and therapeutical target for Alzheimer\u2019s disease. Front Psychiatry 13:1039725.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2022.1039725","journal-title":"Front Psychiatry"},{"key":"4061_CR29","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.neuroimage.2008.01.030","volume":"40","author":"L Truchot","year":"2008","unstructured":"Truchot L, Costes N, Zimmer L, Laurent B, Le Bars D, Thomas-Ant\u00e9rion C, Mercier B, Hermier M, Vighetto A, Krolak-Salmon PA (2008) Distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer\u2019s disease. NeuroImage 40:1251\u20131256.\u00a0https:\/\/doi.org\/10.1016\/j.neuroimage.2008.01.030","journal-title":"NeuroImage"},{"key":"4061_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2015.00220","volume":"9","author":"M Gannon","year":"2015","unstructured":"Gannon M, Che P, Chen Y, Jiao K, Roberson ED, Wang Q (2015) Noradrenergic dysfunction in Alzheimer\u2019s disease. Front Neurosci 9:220.\u00a0https:\/\/doi.org\/10.3389\/fnins.2015.00220","journal-title":"Front Neurosci"},{"key":"4061_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","volume":"97","author":"Y Xu","year":"2012","unstructured":"Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q (2012) Neurotransmitter receptors and cognitive dysfunction in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog Neurobiol 97:1\u201313.\u00a0https:\/\/doi.org\/10.1016\/j.pneurobio.2012.02.002","journal-title":"Prog Neurobiol"},{"key":"4061_CR32","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1523\/jneurosci.4218-08.2008","volume":"28","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yoo MJ, Savonenko A, Stirling W, Price DL, Borchelt DR, Mamounas L, Lyons WE, Blue ME, Lee MK (2008) Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 28:13805\u201313814.\u00a0https:\/\/doi.org\/10.1523\/jneurosci.4218-08.2008","journal-title":"J Neurosci"},{"key":"4061_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","volume":"626","author":"F Caraci","year":"2010","unstructured":"Caraci F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer\u2019s disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626:64\u201371.\u00a0https:\/\/doi.org\/10.1016\/j.ejphar.2009.10.022","journal-title":"Eur J Pharmacol"},{"key":"4061_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mp.2012.168","volume":"18","author":"JH Ledo","year":"2013","unstructured":"Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, De Felice FG, Ferreira ST (2013) Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry 18:1053\u20131054.\u00a0https:\/\/doi.org\/10.1038\/mp.2012.168","journal-title":"Mol Psychiatry"},{"key":"4061_CR35","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","volume":"36","author":"JH Ledo","year":"2016","unstructured":"Ledo JH, Azevedo EP, Beckman D, Ribeiro FC, Santos LE, Razolli DS, Kincheski GC, Melo HM, Bellio M, Teixeira AL, Velloso LA, Foguel D, De Felice FG, Ferreira ST (2016) Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-\u03b2 oligomers in mice. J Neurosci 36:12106\u201312116.\u00a0https:\/\/doi.org\/10.1523\/JNEUROSCI.1269-16.2016","journal-title":"J Neurosci"},{"key":"4061_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00711237","volume":"12","author":"AJ Nazarali","year":"1992","unstructured":"Nazarali AJ, Reynolds GP (1992) Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer\u2019s disease: a postmortem study. Cell Mol Neurobiol 12:581\u2013587.\u00a0https:\/\/doi.org\/10.1007\/BF00711237","journal-title":"Cell Mol Neurobiol"},{"key":"4061_CR37","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","volume":"27","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Tsang SW, Gil-Bea FJ, Francis PT, Lai MK, Marcos B, Chen CP, Ramirez MJ (2006) Involvement of the GABAergic system in depressive symptoms of Alzheimer\u2019s disease. Neurobiol Aging 27:1110\u20131117.\u00a0https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.003","journal-title":"Neurobiol Aging"},{"key":"4061_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/bf03324277","volume":"6","author":"S Ancoli-Israel","year":"1994","unstructured":"Ancoli-Israel S, Klauber MR, Gillin JC, Campbell SS, Hofstetter CR (1994) Sleep in non-institutionalized Alzheimer\u2019s disease patients. Aging (Milano) 6:451\u2013458.\u00a0https:\/\/doi.org\/10.1007\/bf03324277","journal-title":"Aging (Milano)"},{"key":"4061_CR39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jad.2018.12.016","volume":"245","author":"CH Lin","year":"2019","unstructured":"Lin CH, Huang MW, Lin CH, Huang CH, Lane HY (2019) Altered mRNA expressions for N-methyl-D-aspartate receptor-related genes in WBC of patients with major depressive disorder. J Affect Disord 245:1119\u20131125.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2018.12.016","journal-title":"J Affect Disord"},{"key":"4061_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2990.2009.01038.x","volume":"35","author":"G Simic","year":"2009","unstructured":"Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR (2009) Does Alzheimer\u2019s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532\u2013554.\u00a0https:\/\/doi.org\/10.1111\/j.1365-2990.2009.01038.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4061_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","volume":"151","author":"G \u0160imi\u0107","year":"2017","unstructured":"\u0160imi\u0107 G, Babi\u0107 Leko M, Wray S, Harrington CR, Delalle I, Jovanov-Milo\u0161evi\u0107 N, Ba\u017eadona D, Bu\u00e9e L, de Silva R, Di Giovanni G, Wischik CM, Hof PR (2017) Monoaminergic neuropathology in Alzheimer\u2019s disease. Prog Neurobiol 151:101\u2013138.\u00a0https:\/\/doi.org\/10.1016\/j.pneurobio.2016.04.001","journal-title":"Prog Neurobiol"},{"key":"4061_CR42","doi-asserted-by":"publisher","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","volume":"4","author":"JH Roh","year":"2012","unstructured":"Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM (2012) Disruption of the sleep-wake cycle and diurnal fluctuation of \u03b2-amyloid in mice with Alzheimer\u2019s disease pathology. Sci Transl Med 4:150ra122.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.3004291","journal-title":"Sci Transl Med"},{"key":"4061_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk R, Dyck RH, Laferla FM, Antle MC (2010) Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 1. Circadian changes. Brain Res 1348:139\u2013148.\u00a0https:\/\/doi.org\/10.1016\/j.brainres.2010.05.013","journal-title":"Brain Res"},{"key":"4061_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/wnl.32.2.164","volume":"32","author":"W Bondareff","year":"1982","unstructured":"Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164\u2013168.\u00a0https:\/\/doi.org\/10.1212\/wnl.32.2.164","journal-title":"Neurology"},{"key":"4061_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","volume":"39","author":"LL Iversen","year":"1983","unstructured":"Iversen LL, Rossor MN, Reynolds GP, Hills R, Roth M, Mountjoy CQ, Foote SL, Morrison JH, Bloom FE (1983) Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer\u2019s type. Neurosci Lett 39:95\u2013100.\u00a0https:\/\/doi.org\/10.1016\/0304-3940(83)90171-4","journal-title":"Neurosci Lett"},{"key":"4061_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2007.03.002","volume":"30","author":"SD Iversen","year":"2007","unstructured":"Iversen SD, Iversen LL, Dopamine (2007) 50 years in perspective. Trends Neurosci 30:188\u2013193.\u00a0https:\/\/doi.org\/10.1016\/j.tins.2007.03.002","journal-title":"Trends Neurosci"},{"key":"4061_CR47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","volume":"37","author":"L Trillo","year":"2013","unstructured":"Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A (2013) Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. Translating basic science into clinical care. Neurosci Biobehav Rev 37:1363\u20131379.\u00a0https:\/\/doi.org\/10.1016\/j.neubiorev.2013.05.008","journal-title":"Neurosci Biobehav Rev"},{"key":"4061_CR48","doi-asserted-by":"publisher","first-page":"19412","DOI":"10.1038\/s41598-021-99025-1","volume":"11","author":"Y Gloria","year":"2021","unstructured":"Gloria Y, Ceyz\u00e9riat K, Tsartsalis S, Millet P, Tournier BB (2021) Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer\u2019s disease. Sci Rep 11:19412.\u00a0https:\/\/doi.org\/10.1038\/s41598-021-99025-1","journal-title":"Sci Rep"},{"key":"4061_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","volume":"203","author":"D Storga","year":"1996","unstructured":"Storga D, Vrecko K, Birkmayer JG, Reibnegger G (1996) Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci Lett 203:29\u201332.\u00a0https:\/\/doi.org\/10.1016\/0304-3940(95)12256-7","journal-title":"Neurosci Lett"},{"key":"4061_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2016.02.021","volume":"41","author":"P Moreno-Castilla","year":"2016","unstructured":"Moreno-Castilla P, Rodriguez-Duran LF, Guzman-Ramos K, Barcenas-Femat A, Escobar ML, Bermudez-Rattoni F (2016) Dopaminergic neurotransmission dysfunction induced by amyloid-\u03b2 transforms cortical long-term potentiation into long-term depression and produces memory impairment. Neurobiol Aging 41:187\u2013199. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.02.021","journal-title":"Neurobiol Aging"},{"key":"4061_CR51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/jnnp.71.6.777","volume":"71","author":"C Holmes","year":"2001","unstructured":"Holmes C, Smith H, Ganderton R, Arranz M, Collier D, Powell J, Lovestone S (2001) Psychosis and aggression in Alzheimer\u2019s disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry 71:777\u2013779.\u00a0https:\/\/doi.org\/10.1136\/jnnp.71.6.777","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4061_CR52","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.neurobiolaging.2007.11.023","volume":"30","author":"B Borroni","year":"2009","unstructured":"Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A (2009) Role of BDNF Val66Met functional polymorphism in Alzheimer\u2019s disease-related depression. Neurobiol Aging 30:1406\u20131412.\u00a0https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.11.023","journal-title":"Neurobiol Aging"},{"key":"4061_CR53","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1080\/15548627.2021.1909409","volume":"17","author":"A Nobili","year":"2021","unstructured":"Nobili A, La Barbera L, D\u2019Amelio M (2021) Targeting autophagy as a therapeutic strategy to prevent dopamine neuron loss in early stages of Alzheimer disease. Autophagy 17:1278\u20131280.\u00a0https:\/\/doi.org\/10.1080\/15548627.2021.1909409","journal-title":"Autophagy"},{"key":"4061_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","volume":"6","author":"A Martorana","year":"2014","unstructured":"Martorana A, Koch G (2014) Is dopamine involved in Alzheimer\u2019s disease? Front Aging Neurosci 6:252.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2014.00252","journal-title":"Front Aging Neurosci"},{"key":"4061_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fnagi.2015.00067","volume":"7","author":"A Stefani","year":"2015","unstructured":"Stefani A, Olivola E, Liguori C, Hainsworth AH, Saviozzi V, Angileri G, Angelo V, Galati S, Pierantozzi M (2015) Catecholamine-based treatment in AD patients: expectations and delusions. Front Aging Neurosci 7:67.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2015.00067","journal-title":"Front Aging Neurosci"},{"key":"4061_CR56","doi-asserted-by":"publisher","first-page":"174310","DOI":"10.1016\/j.ejphar.2021.174310","volume":"908","author":"P Babaei","year":"2021","unstructured":"Babaei P (2021) NMDA and AMPA receptors dysregulation in Alzheimer\u2019s disease. Eur J Pharmacol 908:174310.\u00a0https:\/\/doi.org\/10.1016\/j.ejphar.2021.174310","journal-title":"Eur J Pharmacol"},{"key":"4061_CR57","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788\u2013801.\u00a0https:\/\/doi.org\/10.1016\/j.neuron.2009.05.012","journal-title":"Neuron"},{"key":"4061_CR58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019409118","volume":"118","author":"H Ma","year":"2021","unstructured":"Ma H, Li C, Wang J, Zhang X, Li M, Zhang R, Huang Z, Zhang Y (2021) Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors. Proc Natl Acad Sci U S A\u00a0118:e2019409118.\u00a0https:\/\/doi.org\/10.1073\/pnas.2019409118","journal-title":"Proc Natl Acad Sci USA"},{"key":"4061_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/187152707780363258","volume":"6","author":"D Bleakman","year":"2007","unstructured":"Bleakman D, Alt A, Witkin JM (2007) AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets 6:117\u2013126.\u00a0https:\/\/doi.org\/10.2174\/187152707780363258","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"4061_CR60","doi-asserted-by":"publisher","first-page":"e12791","DOI":"10.1111\/acel.12791","volume":"17","author":"D Baglietto-Vargas","year":"2018","unstructured":"Baglietto-Vargas D, Prieto GA, Limon A, Forner S, Rodriguez-Ortiz CJ, Ikemura K, Ager RR, Medeiros R, Trujillo-Estrada L, Martini AC, Kitazawa M, Davila JC, Cotman CW, Gutierrez A, LaFerla FM (2018) Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Aging Cell 17:e12791.\u00a0https:\/\/doi.org\/10.1111\/acel.12791","journal-title":"Aging Cell"},{"key":"4061_CR61","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1074\/jbc.M116.774554","volume":"292","author":"S Guntupalli","year":"2017","unstructured":"Guntupalli S, Jang SE, Zhu T, Huganir RL, Widagdo J, Anggono V (2017) GluA1 subunit ubiquitination mediates amyloid-\u03b2-induced loss of surface \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. J Biol Chem 292:8186\u20138194.\u00a0https:\/\/doi.org\/10.1074\/jbc.M116.774554","journal-title":"J Biol Chem"},{"key":"4061_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82:279\u2013293.\u00a0https:\/\/doi.org\/10.1016\/j.neuron.2014.03.030","journal-title":"Neuron"},{"key":"4061_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/stem.2947","volume":"37","author":"R Lin","year":"2019","unstructured":"Lin R, Cai J, Kenyon L, Iozzo R, Rosenwasser R, Iacovitti L (2019) Systemic factors trigger vasculature cells to drive notch signaling and neurogenesis in neural stem cells in the adult brain. Stem Cells 37:395\u2013406.\u00a0https:\/\/doi.org\/10.1002\/stem.2947","journal-title":"Stem Cells"},{"key":"4061_CR64","doi-asserted-by":"publisher","first-page":"105542","DOI":"10.1016\/j.phrs.2021.105542","volume":"167","author":"HQ Wang","year":"2021","unstructured":"Wang HQ, Wang ZZ, Chen NH (2021) The receptor hypothesis and the pathogenesis of depression: genetic bases and biological correlates. Pharmacol Res 167:105542.\u00a0https:\/\/doi.org\/10.1016\/j.phrs.2021.105542","journal-title":"Pharmacol Res"},{"key":"4061_CR65","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fpsyt.2018.00561","volume":"9","author":"C Madeira","year":"2018","unstructured":"Madeira C, Vargas-Lopes C, Brand\u00e3o CO, Reis T, Laks J, Panizzutti R, Ferreira ST (2018) Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer\u2019s disease and depression. Front Psychiatry 9:561.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2018.00561","journal-title":"Front Psychiatry"},{"key":"4061_CR66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11427-014-4637-y","volume":"57","author":"CJ Taylor","year":"2014","unstructured":"Taylor CJ, He R, Bartlett PF (2014) The role of the N-methyl-D-aspartate receptor in the proliferation of adult hippocampal neural stem and precursor cells. Sci China Life Sci 57:403\u2013411.\u00a0https:\/\/doi.org\/10.1007\/s11427-014-4637-y","journal-title":"Sci China Life Sci"},{"key":"4061_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2014.10.028","volume":"225","author":"A Dutta","year":"2015","unstructured":"Dutta A, McKie S, Deakin JFW (2015) Ketamine and other potential glutamate antidepressants. Psychiatry Res 225:1\u201313.\u00a0https:\/\/doi.org\/10.1016\/j.psychres.2014.10.028","journal-title":"Psychiatry Res"},{"key":"4061_CR68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2019.00186","volume":"11","author":"NR Smalheiser","year":"2019","unstructured":"Smalheiser NR, Ketamine (2019) A neglected therapy for Alzheimer disease. Front Aging Neurosci 11:186.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2019.00186","journal-title":"Front Aging Neurosci"},{"key":"4061_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41398-020-0844-4","volume":"10","author":"M Tiger","year":"2020","unstructured":"Tiger M, Veldman ER, Ekman CJ, Halldin C, Svenningsson P, Lundberg J (2020) A randomized placebo-controlled PET study of ketamine\u00b4s effect on serotonin(1B) receptor binding in patients with SSRI-resistant depression. Transl Psychiatry 10:159.\u00a0https:\/\/doi.org\/10.1038\/s41398-020-0844-4","journal-title":"Transl Psychiatry"},{"key":"4061_CR70","doi-asserted-by":"publisher","first-page":"22538","DOI":"10.18632\/aging.103663","volume":"12","author":"L Xie","year":"2020","unstructured":"Xie L, Zhang N, Zhang Q, Li C, Sandhu AF, Iii GW, Lin S, Lv P, Liu Y, Wu Q, Yu S (2020) Inflammatory factors and amyloid \u03b2-induced microglial polarization promote inflammatory crosstalk with astrocytes. Aging 12:22538\u201322549.\u00a0https:\/\/doi.org\/10.18632\/aging.103663","journal-title":"Aging"},{"key":"4061_CR71","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732\u2013741.\u00a0https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.029","journal-title":"Biol Psychiatry"},{"key":"4061_CR72","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrn.2016.69","volume":"17","author":"ES Wohleb","year":"2016","unstructured":"Wohleb ES, Franklin T, Iwata M, Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17:497\u2013511.\u00a0https:\/\/doi.org\/10.1038\/nrn.2016.69","journal-title":"Nat Rev Neurosci"},{"key":"4061_CR73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanct\u00f4t KL, Carvalho AF (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135:373\u2013387.\u00a0https:\/\/doi.org\/10.1111\/acps.12698","journal-title":"Acta Psychiatr Scand"},{"key":"4061_CR74","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","volume":"130","author":"F Caraci","year":"2018","unstructured":"Caraci F, Spampinato SF, Morgese MG, Tascedda F, Salluzzo MG, Giambirtone MC, Caruso G, Munaf\u00f2 A, Torrisi SA, Leggio GM, Trabace L, Nicoletti F, Drago F, Sortino MA, Copani A\u00a0(2018) Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target. Pharmacol Res 130:374\u2013384.\u00a0https:\/\/doi.org\/10.1016\/j.phrs.2018.02.007","journal-title":"Pharmacol Res"},{"key":"4061_CR75","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/glia.23878","volume":"68","author":"J Zhang","year":"2020","unstructured":"Zhang J, He H, Qiao Y, Zhou T, He H, Yi S, Zhang L, Mo L, Li Y, Jiang W, You Z (2020) Priming of microglia with IFN-\u03b3 impairs adult hippocampal neurogenesis and leads to depression-like behaviors and cognitive defects. Glia 68:2674\u20132692.\u00a0https:\/\/doi.org\/10.1002\/glia.23878","journal-title":"Glia"},{"key":"4061_CR76","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","volume":"45","author":"M Hamon","year":"2013","unstructured":"Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharma Biol Psychiatry 45:54\u201363.\u00a0https:\/\/doi.org\/10.1016\/j.pnpbp.2013.04.009","journal-title":"Prog Neuropsychopharma Biol Psychiatry"},{"key":"4061_CR77","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruh\u00e9","year":"2007","unstructured":"Ruh\u00e9 HG, Mason NS, Schene AH (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12:331\u2013359.\u00a0https:\/\/doi.org\/10.1038\/sj.mp.4001949","journal-title":"Mol Psychiatry"},{"key":"4061_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1471-4159.2009.06345.x","volume":"111","author":"B Haenisch","year":"2009","unstructured":"Haenisch B, Bilkei-Gorzo A, Caron MG, B\u00f6nisch H (2009) Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem 111:403\u2013416.\u00a0https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06345.x","journal-title":"J Neurochem"},{"key":"4061_CR79","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/mp.2011.50","volume":"17","author":"JP Jacobsen","year":"2012","unstructured":"Jacobsen JP, Siesser WB, Sachs BD, Peterson S, Cools MJ, Setola V, Folgering JH, Flik G, Caron MG (2012) Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice. Mol Psychiatry 17:694\u2013704.\u00a0https:\/\/doi.org\/10.1038\/mp.2011.50","journal-title":"Mol Psychiatry"},{"key":"4061_CR80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jpsychires.2010.06.005","volume":"45","author":"CG Schipke","year":"2011","unstructured":"Schipke CG, Heuser I, Peters O (2011) Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J Psychiatr Res 45:242\u2013248.\u00a0https:\/\/doi.org\/10.1016\/j.jpsychires.2010.06.005","journal-title":"J Psychiatr Res"},{"key":"4061_CR81","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2015.10.021","volume":"85","author":"Z Kohl","year":"2016","unstructured":"Kohl Z, Ben Abdallah N, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, M\u00fcller CP, Riess O, Masliah E, Nuber S, Winkler J (2016) Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC \u03b1-synuclein transgenic rat model of Parkinson\u2019s disease. Neurobiol Dis 85:206\u2013217.\u00a0https:\/\/doi.org\/10.1016\/j.nbd.2015.10.021","journal-title":"Neurobiol Dis"},{"key":"4061_CR82","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","volume":"70","author":"A Casta\u00f1o","year":"1998","unstructured":"Casta\u00f1o A, Herrera AJ, Cano J, Machado A (1998) Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70:1584\u20131592.\u00a0https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70041584.x","journal-title":"J Neurochem"},{"key":"4061_CR83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.tpj.6500460","volume":"8","author":"M Gratac\u00f2s","year":"2008","unstructured":"Gratac\u00f2s M, Soria V, Urretavizcaya M, Gonz\u00e1lez JR, Crespo JM, Bay\u00e9s M, de Cid R, Mench\u00f3n JM, Vallejo J, Estivill X (2008) A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J 8:101\u2013112.\u00a0https:\/\/doi.org\/10.1038\/sj.tpj.6500460","journal-title":"Pharmacogenomics J"},{"key":"4061_CR84","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature10287","volume":"476","author":"JS Snyder","year":"2011","unstructured":"Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA (2011) Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476:458\u2013461. https:\/\/doi.org\/10.1038\/nature10287","journal-title":"Nature"},{"key":"4061_CR85","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fpsyt.2018.00250","volume":"9","author":"S van den Ameele","year":"2018","unstructured":"van den Ameele S, Fuchs D, Coppens V, de Boer P, Timmers M, Sabbe B, Morrens M (2018) Markers of inflammation and monoamine metabolism indicate accelerated aging in bipolar disorder. Front Psychiatry 9:250.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2018.00250","journal-title":"Front Psychiatry"},{"key":"4061_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.13712","volume":"1437","author":"ME Bauer","year":"2019","unstructured":"Bauer ME, Teixeira AL (2019) Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 1437:57\u201367.\u00a0https:\/\/doi.org\/10.1111\/nyas.13712","journal-title":"Ann N Y Acad Sci"},{"key":"4061_CR87","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fncel.2014.00146","volume":"8","author":"A Mouihate","year":"2014","unstructured":"Mouihate A (2014) TLR4-mediated Brain Inflammation halts neurogenesis: impact of hormonal replacement therapy. Front Cell Neurosci 8:146.\u00a0https:\/\/doi.org\/10.3389\/fncel.2014.00146","journal-title":"Front Cell Neurosci"},{"key":"4061_CR88","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/brain\/awaa405","volume":"144","author":"S Hayley","year":"2021","unstructured":"Hayley S, Hakim AM, Albert PR (2021) Depression,\u00a0dement immune dysregulation. Brain 144:746\u2013760.\u00a0https:\/\/doi.org\/10.1093\/brain\/awaa405","journal-title":"Brain"},{"key":"4061_CR89","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00213-018-5137-8","volume":"236","author":"M Amani","year":"2019","unstructured":"Amani M, Shokouhi G, Salari AA (2019) Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease. Psychopharmacology 236:1281\u20131292.\u00a0https:\/\/doi.org\/10.1007\/s00213-018-5137-8","journal-title":"Psychopharmacology"},{"key":"4061_CR90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jad.2018.05.030","volume":"238","author":"MG Morgese","year":"2018","unstructured":"Morgese MG, Schiavone S, Bove M, Mhillaj E, Tucci P, Trabace L (2018) Sub-chronic celecoxib prevents soluble beta amyloid-induced depressive-like behaviour in rats. J Affect Disord 238:118\u2013121.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2018.05.030","journal-title":"J Affect Disord"},{"key":"4061_CR91","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/87945","volume":"7","author":"T Wyss-Coray","year":"2001","unstructured":"Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7:612\u2013618.\u00a0https:\/\/doi.org\/10.1038\/87945","journal-title":"Nat Med"},{"key":"4061_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010064","author":"G Caruso","year":"2019","unstructured":"Caruso G, Fresta CG, Musso N, Giambirtone M, Grasso M, Spampinato SF, Merlo S, Drago F, Lazzarino G, Sortino MA, Lunte SM, Caraci F (2019) Carnosine prevents A\u03b2-induced oxidative stress and inflammation in microglial cells: a key role of TGF-\u03b21. Cells\u00a08:64.\u00a0https:\/\/doi.org\/10.3390\/cells8010064","journal-title":"Cells"},{"key":"4061_CR93","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fphar.2019.00693","volume":"10","author":"SA Torrisi","year":"2019","unstructured":"Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso G, Fidilio A, Musso N, Sanfilippo G, Tascedda F, Palmeri A, Salomone S, Drago F, Puzzo D, Leggio GM, Caraci F (2019) Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by A\u03b2(1\u201342) oligomers in mice: a key role of transforming growth factor-\u03b21. Front Pharmacol 10:693.\u00a0https:\/\/doi.org\/10.3389\/fphar.2019.00693","journal-title":"Front Pharmacol"},{"key":"4061_CR94","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.intimp.2021.108488","volume":"104","author":"K Abu-Elfotuh","year":"2022","unstructured":"Abu-Elfotuh K, Al-Najjar AH, Mohammed AA, Aboutaleb AS, Badawi GA (2022) Fluoxetine ameliorates Alzheimer\u2019s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2\/HO-1 and hindering TLR4\/NLRP3 inflammasome signaling pathway. Int Immunopharmacol 104:108488.\u00a0https:\/\/doi.org\/10.1016\/j.intimp.2021.108488","journal-title":"Int Immunopharmacol"},{"key":"4061_CR95","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1111\/brv.12750","volume":"96","author":"AA Milligan","year":"2021","unstructured":"Milligan AA, Porter T, Quek H, White A, Haynes J, Jackaman C, Villemagne V, Munyard K, Laws SM, Verdile G, Groth D (2021) Chronic stress and Alzheimer\u2019s disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia. Biol Rev Camb Philos Soc 96:2209\u20132228.\u00a0https:\/\/doi.org\/10.1111\/brv.12750","journal-title":"Biol Rev Camb Philos Soc"},{"key":"4061_CR96","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/S1041610218001199","volume":"31","author":"ML Barca","year":"2019","unstructured":"Barca ML, Eldholm RS, Persson K, Bjorklof GH, Borza T, Telenius E, Knapskog AB, Braekhus A, Saltvedt I, Selbaek G, Engedal K (2019) Cortisol levels among older people with and without depression and dementia. Int Psychogeriatr 31:597\u2013601.\u00a0https:\/\/doi.org\/10.1017\/S1041610218001199","journal-title":"Int Psychogeriatr"},{"key":"4061_CR97","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13195-022-01139-9","volume":"14","author":"S Ouanes","year":"2022","unstructured":"Ouanes S, Rabl M, Clark C, Kirschbaum C, Popp J (2022) Persisting neuropsychiatric symptoms, Alzheimer\u2019s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate. Alzheimers Res Ther 14:190.\u00a0https:\/\/doi.org\/10.1186\/s13195-022-01139-9","journal-title":"Alzheimers Res Ther"},{"key":"4061_CR98","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1124\/pr.112.005892","volume":"64","author":"M Jo\u00ebls","year":"2012","unstructured":"Jo\u00ebls M, Sarabdjitsingh RA, Karst H (2012) Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev 64:901\u2013938.\u00a0https:\/\/doi.org\/10.1124\/pr.112.005892","journal-title":"Pharmacol Rev"},{"key":"4061_CR99","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yfrne.2015.12.001","volume":"41","author":"J Herbert","year":"2016","unstructured":"Herbert J, Lucassen PJ (2016) Depression as a risk factor for Alzheimer\u2019s disease: genes, steroids, cytokines and neurogenesis\u2014what do we need to know? Front Neuroendocrinol 41:153\u2013171.\u00a0https:\/\/doi.org\/10.1016\/j.yfrne.2015.12.001","journal-title":"Front Neuroendocrinol"},{"key":"4061_CR100","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.yfrne.2020.100877","volume":"60","author":"T Watermeyer","year":"2021","unstructured":"Watermeyer T, Robb C, Gregory S, Udeh-Momoh C (2021) Therapeutic implications of hypothalamic-pituitaryadrenal-axis modulation in Alzheimer\u2019s disease: a narrative review of pharmacological and lifestyle interventions. Front Neuroendocrinol 60:100877.\u00a0https:\/\/doi.org\/10.1016\/j.yfrne.2020.100877","journal-title":"Front Neuroendocrinol"},{"key":"4061_CR101","doi-asserted-by":"publisher","first-page":"104568","DOI":"10.1016\/j.nbd.2019.104568","volume":"132","author":"M Pedrazzoli","year":"2019","unstructured":"Pedrazzoli M, Losurdo M, Paolone G, Medelin M, Jaupaj L, Cisterna B, Slanzi A, Malatesta M, Coco S, Buffelli M (2019) Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer\u2019s disease. Neurobiol Dis 132:104568.\u00a0https:\/\/doi.org\/10.1016\/j.nbd.2019.104568","journal-title":"Neurobiol Dis"},{"key":"4061_CR102","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14728222.2019.1572747","volume":"23","author":"NK Popova","year":"2019","unstructured":"Popova NK, Naumenko VS (2019) Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem. Expert Opin Ther Targets 23:227\u2013239.\u00a0https:\/\/doi.org\/10.1080\/14728222.2019.1572747","journal-title":"Expert Opin Ther Targets"},{"key":"4061_CR103","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","volume":"45","author":"K Fukumoto","year":"2020","unstructured":"Fukumoto K, Foga\u00e7a MV, Liu RJ, Duman CH, Li XY, Chaki S, Duman RS (2020) Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT(1A) receptor stimulation. Neuropsychopharmacology 45:1725\u20131734.\u00a0https:\/\/doi.org\/10.1038\/s41386-020-0705-0","journal-title":"Neuropsychopharmacology"},{"key":"4061_CR104","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.pneurobio.2022.102333","volume":"217","author":"J Leschik","year":"2022","unstructured":"Leschik J, Gentile A, Cicek C, P\u00e9ron S, Tevosian M, Beer A, Radyushkin K, Bludau A, Ebner K, Neumann I, Singewald N, Berninger B, Lessmann V, Lutz B (2022) Brain-derived neurotrophic factor expression in serotonergic neurons improves stress resilience and promotes adult hippocampal neurogenesis. Prog Neurobiol 217:102333.\u00a0https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102333","journal-title":"Prog Neurobiol"},{"key":"4061_CR105","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.biopsych.2018.09.026","volume":"85","author":"H Oh","year":"2019","unstructured":"Oh H, Piantadosi SC, Rocco BR, Lewis DA, Watkins SC, Sibille E (2019) The role of dendritic brain-derived neurotrophic factor transcripts on altered inhibitory circuitry in depression. Biol Psychiatry 85:517\u2013526.\u00a0https:\/\/doi.org\/10.1016\/j.biopsych.2018.09.026","journal-title":"Biol Psychiatry"},{"key":"4061_CR106","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13148-021-01136-z","volume":"13","author":"J Bakusic","year":"2021","unstructured":"Bakusic J, Vrieze E, Ghosh M, Pizzagalli DA, Bekaert B, Claes S, Godderis L (2021) Interplay of Val66Met and BDNF methylation: effect on reward learning and cognitive performance in major depression. Clin Epigenetics 13:149.\u00a0https:\/\/doi.org\/10.1186\/s13148-021-01136-z","journal-title":"Clin Epigenetics"},{"key":"4061_CR107","doi-asserted-by":"publisher","first-page":"655.e5","DOI":"10.1016\/j.celrep.2019.06.054","volume":"28","author":"ZH Wang","year":"2019","unstructured":"Wang ZH, Xiang J, Liu X, Yu SP, Manfredsson FP, Sandoval IM, Wu S, Wang JZ, Ye K (2019) Deficiency in BDNF\/TrkB neurotrophic activity stimulates \u03b4-Secretase by upregulating C\/EBP\u03b2 in Alzheimer\u2019s disease. Cell Rep 28:655.e5\u2013669.e5.\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2019.06.054","journal-title":"Cell Rep"},{"key":"4061_CR108","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nat Med 15:331\u2013337.\u00a0https:\/\/doi.org\/10.1038\/nm.1912","journal-title":"Nat Med"},{"key":"4061_CR109","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jad.2018.08.025","volume":"241","author":"PV Nunes","year":"2018","unstructured":"Nunes PV, Nascimento CF, Kim HK, Andreazza AC, Brentani HP, Suemoto CK, Leite REP, Ferretti-Rebustini REL, Pasqualucci CA, Nitrini R, Grinberg LT, Yong LT, Jacob-Filho W, Lafer B (2018) Low brain-derived neurotrophic factor levels in post-mortem brains of older adults with depression and dementia in a large clinicopathological sample. J Affect Disord 241:176\u2013181.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2018.08.025","journal-title":"J Affect Disord"},{"key":"4061_CR110","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","volume":"159","author":"M Colaianna","year":"2010","unstructured":"Colaianna M, Tucci P, Zotti M, Morgese MG, Schiavone S, Govoni S, Cuomo V, Trabace L (2010) Soluble beta amyloid(1\u201342): a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159:1704\u20131715.\u00a0https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00669.x","journal-title":"Br J Pharmacol"},{"key":"4061_CR111","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pnpbp.2017.05.004","volume":"78","author":"S Schiavone","year":"2017","unstructured":"Schiavone S, Tucci P, Mhillaj E, Bove M, Trabace L, Morgese MG (2017) Antidepressant drugs for beta amyloid-induced depression: a new standpoint? Prog Neuropsychopharmacol Biol Psychiatry 78:114\u2013122.\u00a0https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4061_CR112","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00406-007-0728-0","volume":"257","author":"B Cz\u00e9h","year":"2007","unstructured":"Cz\u00e9h B, Lucassen PJ (2007) What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257:250\u2013260.\u00a0https:\/\/doi.org\/10.1007\/s00406-007-0728-0","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4061_CR113","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mp.2010.80","volume":"16","author":"G MacQueen","year":"2011","unstructured":"MacQueen G, Frodl T (2011) The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 16:252\u2013264.\u00a0https:\/\/doi.org\/10.1038\/mp.2010.80","journal-title":"Mol Psychiatry"},{"key":"4061_CR114","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68\u201372.\u00a0https:\/\/doi.org\/10.1126\/science.1222939","journal-title":"Science"},{"key":"4061_CR115","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","volume":"25","author":"RB Price","year":"2020","unstructured":"Price RB, Duman R (2020) Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry 25:530\u2013543.\u00a0https:\/\/doi.org\/10.1038\/s41380-019-0615-x","journal-title":"Mol Psychiatry"},{"key":"4061_CR116","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/npp.2013.5","volume":"38","author":"M Boldrini","year":"2013","unstructured":"Boldrini M, Santiago AN, Hen R, Dwork AJ, Rosoklija GB, Tamir H, Arango V, John MJ (2013) Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 38:1068\u20131077.\u00a0https:\/\/doi.org\/10.1038\/npp.2013.5","journal-title":"Neuropsychopharmacology"},{"key":"4061_CR117","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S1474-4422(17)30343-5","volume":"16","author":"G Halliday","year":"2017","unstructured":"Halliday G (2017) Pathology and hippocampal atrophy in Alzheimer\u2019s disease. Lancet Neurol 16:862\u2013864.\u00a0https:\/\/doi.org\/10.1016\/S1474-4422(17)30343-5","journal-title":"Lancet Neurol"},{"key":"4061_CR118","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ng.2250","volume":"44","author":"JL Stein","year":"2012","unstructured":"Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann \u00d8, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ, Langan C, Lopez LM, Hansell NK, Hwang KS, Kim S, Laje G, Lee PH, Liu X, Loth E, Lourdusamy A, Mattingsdal M, Mohnke S, Maniega SM, Nho K, Nugent AC, O'Brien C, Papmeyer M, P\u00fctz B, Ramasamy A, Rasmussen J, Rijpkema M, Risacher SL, Roddey JC, Rose EJ, Ryten M, Shen L, Sprooten E, Strengman E, Teumer A, Trabzuni D, Turner J, van Eijk K, van Erp TG, van Tol MJ, Wittfeld K, Wolf C, Woudstra S, Aleman A, Alhusaini S, Almasy L, Binder EB, Brohawn DG, Cantor RM, Carless MA, Corvin A, Czisch M, Curran JE, Davies G, de Almeida MA, Delanty N, Depondt C, Duggirala R, Dyer TD, Erk S, Fagerness J, Fox PT, Freimer NB, Gill M, G\u00f6ring HH, Hagler DJ, Hoehn D, Holsboer F, Hoogman M, Hosten N, Jahanshad N, Johnson MP, Kasperaviciute D, Kent JW Jr, Kochunov P, Lancaster JL, Lawrie SM, Liewald DC, Mandl R, Matarin M, Mattheisen M, Meisenzahl E, Melle I, Moses EK, M\u00fchleisen TW, Nauck M, N\u00f6then MM, Olvera RL, Pandolfo M, Pike GB, Puls R, Reinvang I, Renter\u00eda ME, Rietschel M, Roffman JL, Royle NA, Rujescu D, Savitz J, Schnack HG, Schnell K, Seiferth N, Smith C, Steen VM, Vald\u00e9s Hern\u00e1ndez MC, Van den Heuvel M, van der Wee NJ, Van Haren NE, Veltman JA, V\u00f6lzke H, Walker R, Westlye LT, Whelan CD, Agartz I, Boomsma DI, Cavalleri GL, Dale AM, Djurovic S, Drevets WC, Hagoort P, Hall J, Heinz A, Jack CR Jr, Foroud TM, Le Hellard S, Macciardi F, Montgomery GW, Poline JB, Porteous DJ, Sisodiya SM, Starr JM, Sussmann J, Toga AW, Veltman DJ, Walter H, Weiner MW, Bis JC, Ikram MA, Smith AV, Gudnason V, Tzourio C, Vernooij MW, Launer LJ, DeCarli C, Seshadri S, Andreassen OA, Apostolova LG, Bastin ME, Blangero J, Brunner HG, Buckner RL, Cichon S, Coppola G, de Zubicaray GI, Deary IJ, Donohoe G, de Geus EJ, Espeseth T, Fern\u00e1ndez G, Glahn DC, Grabe HJ, Hardy J, Hulshoff Pol HE, Jenkinson M, Kahn RS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meyer-Lindenberg A, Morris DW, M\u00fcller-Myhsok B, Nichols TE, Ophoff RA, Paus T, Pausova Z, Penninx BW, Potkin SG, S\u00e4mann PG, Saykin AJ, Schumann G, Smoller JW, Wardlaw JM, Weale ME, Martin NG, Franke B, Wright MJ, Thompson PM (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44:552\u2013561. https:\/\/doi.org\/10.1038\/ng.2250","journal-title":"Nat Genet"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-04061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-04061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-04061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T09:06:23Z","timestamp":1708851983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-04061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-04061-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"31 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}